Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Synergetic role of As-Ag-TiO<sub>2</sub> nanoparticles on organogenesis dependent <i>Agrobacterium</i> mediated pea (<i>Pisum sativum</i> L.) genetic transformation.

3 Biotech·2026

Same author

Halo-Substituted Adamantyl Benzamides as Digestive Enzyme Modulators: Synthesis, DFT Analysis, and Biological Evaluation.

Chemistry & biodiversity·2026

Same author

Beyond the bladder: case series of <i>Mycobacterium bovis</i> bacillus Calmette-Guérin infections following intravesical instillation.

ASM case reports·2026

Same author

Honokiol and Its Emerging Role in Breast Cancer Therapy.

Cancers·2026

Same author

Impact of Synthetic Lesional MR Images in Automated Focal Cortical Dysplasia Detection in Low-Data Scenarios.

Journal of neuroimaging : official journal of the American Society of Neuroimaging·2026

Same author

Robust ranking of renewable energy alternatives handling uncertainty using novel hesitant bi-fuzzy MEREC-MOORA and Dombi aggregation approach.

Scientific reports·2026

Search research articles

Related Experiment Video

Updated: Jun 22, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Promising Combinatorial Therapeutic Strategies against Non-Small Cell Lung Cancer.

Prabhjot Kaur¹, Santosh Kumar Singh¹, Manoj K Mishra²

¹Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA 30310, USA.

|June 27, 2024

Summary

Targeted therapies, including tyrosine kinase inhibitors (TKIs), are revolutionizing non-small cell lung cancer (NSCLC) treatment. Advances in personalized medicine are improving patient survival rates.

Keywords:

PARP inhibitors PDL-1 clinical trials immune checkpoint inhibitors nanobodies natural drug therapy tyrosine kinase inhibitors

More Related Videos

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Related Experiment Videos

Last Updated: Jun 22, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Area of Science:

Oncology
Molecular Biology
Pharmacology

Background:

Non-small cell lung cancer (NSCLC) is a heterogeneous disease with diverse cellular and histological subtypes.
Genetic mutations in NSCLC present diagnostic and therapeutic challenges.
Recent advancements in molecular and immunohistochemical techniques are improving patient outcomes.

Purpose of the Study:

To review the latest progress in targeted therapies for NSCLC.
To discuss challenges and future directions in NSCLC treatment development.
To highlight the impact of personalized medicine on patient survival.

Main Methods:

Review of recent randomized studies and clinical trials.
Analysis of advancements in molecular and immunohistochemical techniques.
Examination of emerging targeted therapies including TKIs, immunotherapy, and nanobodies.

Main Results:

Targeted therapies, particularly TKIs, show remarkable efficacy in NSCLC patients with actionable mutations.
Personalized medicine approaches have significantly improved progression-free survival.
Randomized studies indicate enhanced overall survival with targeted and natural drug therapies.

Conclusions:

Targeted therapies represent a paradigm shift in NSCLC management, ushering in an era of personalized medicine.
Continued research into novel therapeutic strategies is crucial for further improving patient outcomes.
The integration of molecular profiling and advanced therapies holds promise for overcoming NSCLC complexity.